LiuYing

Liuying Biotech is a Shanghai-based life sciences company specializing in high-throughput single-cell microfluidic technology. The company develops and commercializes integrated platforms for rapid antibody discovery, cell line development, and enzyme screening, aiming to significantly reduce the time and cost of biopharmaceutical R&D. Their core technology utilizes picoliter-scale droplet microfluidics to perform functional screening of millions of single cells in a single day. Liuying's solutions are primarily used by pharmaceutical companies and research institutions for biologics development and synthetic biology applications. The company is supported by prominent investors such as Sequoia China and IDG Capital.